Dr. Jeneba Abass-Shereef, MD

Dr. Abass-Shereef practices at Jersey City Medical Center in Jersey City, New Jersey, part of RWJBarnabas Health.

Dr. Abass-Shereef's NPI, 1679960942, was assigned on April 23, 2015. Dr. Abass-Shereef holds New Jersey license 25MA10364900.

Dr. Abass-Shereef's primary practice is Jersey City Medical Center, at 355 Grand Street, Jersey City, NJ 07302 in Hudson County. The practice phone is (201) 915-2000.

Dr. Abass-Shereef's primary practice is Jersey City Medical Center in Jersey City, New Jersey, part of RWJBarnabas Health. Dr. Abass-Shereef is also affiliated with NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Abass-Shereef to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abass-Shereef practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Abass-Shereef's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. Abass-Shereef's licenses on file in 2 states: New Jersey and Ohio.

CMS data shows 160 Medicare services from Dr. Abass-Shereef across 3 procedure codes in 2024, for 122 Medicare patients. Medicare paid $14,867 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Abass-Shereef in 2024. The largest group is 65 to 74, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abass-Shereef's median patient age at 44, with 58% women.

In 2024, Dr. Abass-Shereef wrote 123 Medicare Part D claims for 86 patients. 93% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $136 in total drug cost. In 2023, CMS named 16 claims across 1 drug.

Dr. Abass-Shereef accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abass-Shereef as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Abass-Shereef from 2 drug and device companies from 2019 to 2020. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $64.